23.51 USD
▼-0.76-3.13%
盘后 25.50 0.00%
2026-09-15
市值
$3.29B
市盈率
121.35
EPS
0.21
股息率
—
52 周区间
16.57 – 31.77
成交量
3.46M
Beta
1.50
目标价
36.88
52W 低 16.5752W 高 31.77
价格走势
公司简介
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company’s lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Bio...